Effects of Salvinorin A in Healthy Controls
This trial is active, not recruiting.
|Treatments||salvinorin a, placebo|
|Collaborator||National Alliance for Research on Schizophrenia and Depression|
|Start date||January 2009|
|End date||August 2017|
|Trial size||41 participants|
|Trial identifier||NCT00700596, 0707002884|
This study evaluates the effects of Salvinorin A (SA). SA is the active ingredient of the plant Salvia divinorum that is known to have been used by Mexican Indians as part of religious rituals. The purpose of this project is to understand what people experience when they consume Salvinorin A.
|Intervention model||crossover assignment|
|Masking||double blind (subject, caregiver, investigator, outcomes assessor)|
|Primary purpose||basic science|
Salvinorin A (SA)
Control or Placebo SA
Positive and Negative Syndrome Scale, Clinician Administered Dissociative Symptoms Scale, Visual Analog Scale, Assessment of Opioid Effects, Cognitive Testing
time frame: Time Frame: -30, +10, +30, +90, +120. +200
Male or female participants from 18 years up to 45 years old.
Inclusion Criteria: -Previous exposure to inhaled Salvinorin A (SA).
|Official title||Psychotomimetic Effects of Kappa Opioid Receptor Agonist Salvinorin A in Healthy Controls|
|Principal investigator||Mohini Ranganathan, M.D.|
Call for more information